We serve Chemical Name:N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% CAS:155997-19-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97%
CAS.NO:155997-19-6
Synonyms:N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97%
Molecular Formula:C14H11F2NO2
Molecular Weight:263.2394464
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% Use and application,N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% technical grade,usp/ep/jp grade.
Related News: There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% manufacturer Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% supplier Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% vendor In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. N-(2,6-Difluorophenyl)-4-MethoxybenzaMide, 97% factory Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.
